ECSP21024078A - Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen - Google Patents
Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienenInfo
- Publication number
- ECSP21024078A ECSP21024078A ECSENADI202124078A ECDI202124078A ECSP21024078A EC SP21024078 A ECSP21024078 A EC SP21024078A EC SENADI202124078 A ECSENADI202124078 A EC SENADI202124078A EC DI202124078 A ECDI202124078 A EC DI202124078A EC SP21024078 A ECSP21024078 A EC SP21024078A
- Authority
- EC
- Ecuador
- Prior art keywords
- pyrimidonil
- preparation
- pharmaceutical compositions
- compositions containing
- new amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Compuestos de fórmula (I): (VER FORMULA EN LA MEMORIA TECNICA) en donde R1, R2, R3, R4, R5, n y Q son como se definen en la descripción. Medicamentos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18306377 | 2018-10-19 | ||
| EP19305936 | 2019-07-12 | ||
| PCT/EP2019/078318 WO2020079205A1 (en) | 2018-10-19 | 2019-10-18 | New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP21024078A true ECSP21024078A (es) | 2021-05-31 |
Family
ID=68234009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSENADI202124078A ECSP21024078A (es) | 2018-10-19 | 2021-04-07 | Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20210355106A1 (es) |
| EP (1) | EP3866930A1 (es) |
| JP (1) | JP2022505122A (es) |
| KR (1) | KR20210081371A (es) |
| CN (1) | CN113038990A (es) |
| AU (1) | AU2019360391A1 (es) |
| BR (1) | BR112021006714A2 (es) |
| CA (1) | CA3116089A1 (es) |
| CL (1) | CL2021000973A1 (es) |
| CO (1) | CO2021004553A2 (es) |
| CR (1) | CR20210173A (es) |
| DO (1) | DOP2021000063A (es) |
| EC (1) | ECSP21024078A (es) |
| IL (1) | IL282218A (es) |
| JO (1) | JOP20210063A1 (es) |
| MA (1) | MA53900A (es) |
| MX (1) | MX2021004379A (es) |
| NI (1) | NI202100024A (es) |
| PE (1) | PE20211649A1 (es) |
| PH (1) | PH12021550788A1 (es) |
| PY (1) | PY1987737A (es) |
| SG (1) | SG11202103279RA (es) |
| TW (1) | TW202028188A (es) |
| UY (1) | UY38423A (es) |
| WO (1) | WO2020079205A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020234859B2 (en) | 2019-03-11 | 2025-03-13 | Inflarx Gmbh | Fused piperidinyl bicyclic and related compounds as modulators of C5a receptor |
| CN118496197A (zh) | 2019-12-20 | 2024-08-16 | 拜耳公司 | 取代的噻吩甲酰胺、噻吩甲酸及其衍生物 |
| CN114507163A (zh) * | 2020-11-16 | 2022-05-17 | 尚科生物医药(上海)有限公司 | 一种制备2-氟-5-甲氧基苯磺酰氯的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEP20207161B (en) * | 2016-06-10 | 2020-10-12 | Servier Lab | New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them |
| FR3052452B1 (fr) * | 2016-06-10 | 2018-06-22 | Les Laboratoires Servier | Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB201617758D0 (en) * | 2016-10-20 | 2016-12-07 | Almac Discovery Limited | Pharmaceutical compounds |
-
2019
- 2019-10-17 UY UY0001038423A patent/UY38423A/es unknown
- 2019-10-18 JO JOP/2021/0063A patent/JOP20210063A1/ar unknown
- 2019-10-18 JP JP2021521034A patent/JP2022505122A/ja active Pending
- 2019-10-18 US US17/282,898 patent/US20210355106A1/en not_active Abandoned
- 2019-10-18 CR CR20210173A patent/CR20210173A/es unknown
- 2019-10-18 PY PY201901987737A patent/PY1987737A/es unknown
- 2019-10-18 SG SG11202103279RA patent/SG11202103279RA/en unknown
- 2019-10-18 AU AU2019360391A patent/AU2019360391A1/en not_active Abandoned
- 2019-10-18 CN CN201980074282.0A patent/CN113038990A/zh not_active Withdrawn
- 2019-10-18 TW TW108137746A patent/TW202028188A/zh unknown
- 2019-10-18 KR KR1020217014709A patent/KR20210081371A/ko not_active Withdrawn
- 2019-10-18 CA CA3116089A patent/CA3116089A1/en active Pending
- 2019-10-18 MX MX2021004379A patent/MX2021004379A/es unknown
- 2019-10-18 PE PE2021000517A patent/PE20211649A1/es unknown
- 2019-10-18 MA MA053900A patent/MA53900A/fr unknown
- 2019-10-18 EP EP19786808.6A patent/EP3866930A1/en not_active Withdrawn
- 2019-10-18 BR BR112021006714-0A patent/BR112021006714A2/pt not_active Application Discontinuation
- 2019-10-18 WO PCT/EP2019/078318 patent/WO2020079205A1/en not_active Ceased
-
2021
- 2021-04-07 EC ECSENADI202124078A patent/ECSP21024078A/es unknown
- 2021-04-09 DO DO2021000063A patent/DOP2021000063A/es unknown
- 2021-04-09 NI NI202100024A patent/NI202100024A/es unknown
- 2021-04-09 PH PH12021550788A patent/PH12021550788A1/en unknown
- 2021-04-11 IL IL282218A patent/IL282218A/en unknown
- 2021-04-12 CO CONC2021/0004553A patent/CO2021004553A2/es unknown
- 2021-04-16 CL CL2021000973A patent/CL2021000973A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO2021004553A2 (es) | 2021-04-30 |
| CR20210173A (es) | 2021-05-11 |
| UY38423A (es) | 2021-02-26 |
| JOP20210063A1 (ar) | 2023-01-30 |
| MA53900A (fr) | 2022-01-26 |
| TW202028188A (zh) | 2020-08-01 |
| IL282218A (en) | 2021-05-31 |
| CA3116089A1 (en) | 2020-04-23 |
| JP2022505122A (ja) | 2022-01-14 |
| SG11202103279RA (en) | 2021-04-29 |
| NI202100024A (es) | 2021-08-24 |
| AU2019360391A1 (en) | 2021-05-13 |
| MX2021004379A (es) | 2021-06-04 |
| PH12021550788A1 (en) | 2021-10-18 |
| PE20211649A1 (es) | 2021-08-24 |
| DOP2021000063A (es) | 2021-08-31 |
| BR112021006714A2 (pt) | 2021-07-27 |
| CL2021000973A1 (es) | 2021-11-19 |
| CN113038990A (zh) | 2021-06-25 |
| KR20210081371A (ko) | 2021-07-01 |
| WO2020079205A1 (en) | 2020-04-23 |
| US20210355106A1 (en) | 2021-11-18 |
| EP3866930A1 (en) | 2021-08-25 |
| PY1987737A (es) | 2021-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP18090144A (es) | Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| ECSP18090046A (es) | Nuevos derivados piperidinilo sustituidos con hetero(arilo), un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| ECSP18053634A (es) | Nuevos derivados de amonio, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| ECSP17082825A (es) | Nuevos derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| ECSP17083003A (es) | Nuevos derivados bicíclicos, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| ECSP18023286A (es) | NUEVOS DERIVADOS DE PIRROLO[2,3-d]PIRIMIDINA, UN PROCESO PARA SU PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN | |
| CU20140143A7 (es) | Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| ECSP17082546A (es) | Nuevos derivados aminoácido, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| MX2017016997A (es) | Nuevos derivados hidroxiester, un proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
| DOP2018000083A (es) | NUEVOS DERIVADOS DE IMIDAZO[4,5-b]PIRIDINA, UN PROCESO PARA SU PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN | |
| ECSP21024078A (es) | Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| MX2020014327A (es) | Nuevos derivados de amino-pirimidonilo un proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
| PY1736656A (es) | Nuevos derivados piperidinilo sustituidos con hetero(arilo), un proceso para su preparación y composiciones farmacéuticas que los contienen |